Latest News about Biotech
Recent news which mentions Biotech
From Benzinga
Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals
February 10, 2025
From Benzinga
What's Going On With Bristol Myers Squibb Stock On Monday?
February 10, 2025
From Benzinga
Incyte Q4 Earnings: EPS Miss, Strong Jakafi And Opzelura Sales, Says 2025 To Be Catalyst Rich Including 4 Launches
February 10, 2025
From Benzinga
Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
February 10, 2025
From Benzinga
Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
February 10, 2025
From Benzinga
EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025
February 10, 2025
From Benzinga
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
February 10, 2025
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower On Friday?
February 07, 2025
From Benzinga
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
February 07, 2025
From Benzinga
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
February 07, 2025
From Benzinga
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
February 07, 2025
From Benzinga
Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing
February 06, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.